|
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
| 38.74 AUD | -4.94% |
|
-8.45% | +12.70% |
| 13/04 | Ramsay Reportedly Hints at Possible UK Departure | CI |
| 08/04 | Psyence Biomedical Ltd Expands Australian Clinical Site Network And Advances NPX-5 Supported Clinical Activities | CI |
| Capitalization | 936.96Cr 670.97Cr 572.54Cr 525.16Cr 496.71Cr 916.62Cr 63TCr 6.17TCr 2.43TCr 30TCr 2.52TCr 2.46TCr 1,06900Cr | P/E ratio 2026 * |
31.3x | P/E ratio 2027 * | 24.5x |
|---|---|---|---|---|---|
| Enterprise value | 1.66TCr 1.19TCr 1.01TCr 929.61Cr 879.25Cr 1.62TCr 1,11400Cr 11TCr 4.3TCr 53TCr 4.45TCr 4.36TCr 1,89300Cr | EV / Sales 2026 * |
0.87x | EV / Sales 2027 * | 0.85x |
| Free-Float |
78.44% | Yield 2026 * |
2.08% | Yield 2027 * | 2.55% |
Last Transcript: Ramsay Health Care Limited
| 1 day | -3.93% | ||
| 1 week | -3.40% | ||
| Current month | +0.36% | ||
| 1 month | -1.63% | ||
| 3 months | +5.27% | ||
| 6 months | +26.45% | ||
| Current year | +13.94% |
| 1 week | 39.02 |  | 42.74 |
| 1 month | 38.33 | | 42.74 |
| Current year | 34.38 | | 44.73 |
| 1 year | 30.39 | | 44.73 |
| 3 years | 30.39 | | 66.83 |
| 5 years | 30.39 | | 84.58 |
| 10 years | 30.39 | | 84.58 |
| Manager | Title | Age | Since |
|---|---|---|---|
Natalie Davis
CEO | Chief Executive Officer | - | - |
Anthony Neilson
DFI | Director of Finance/CFO | 55 | 24/11/2025 |
John Doulis
CTO | Chief Tech/Sci/R&D Officer | - | - |
| Director | Title | Age | Since |
|---|---|---|---|
Michael Siddle
CHM | Chairman | - | 27/05/2014 |
David Thodey
CHM | Chairman | 72 | 28/11/2023 |
Catriona Deans
BRD | Director/Board Member | 58 | 15/11/2018 |
| Name | Varia. Jan 1. | Weight | AuM | |
|---|---|---|---|---|
 | -.--% | 0.9% | 1 M€ | |
| +1.55% | 0.28% | 27 M€ |
| Change | 5d. change | 1-year change | 3-years change | Capi.($) | ||
|---|---|---|---|---|---|---|
| -3.68% | -3.40% | +19.36% | -41.35% | 681.4Cr | |
| +0.80% | +0.69% | +27.87% | +53.75% | 1.95TCr | |
| +1.75% | +2.49% | -23.39% | -54.69% | 1.32TCr | |
| -1.06% | +1.94% | +7.27% | +75.68% | 1.19TCr | |
| -2.88% | -5.91% | +52.56% | +88.06% | 1.12TCr | |
| -0.58% | -2.92% | +3.20% | +60.44% | 1.02TCr | |
| 0.00% | 0.00% | -21.19% | -36.41% | 918.58Cr | |
| +0.71% | +8.57% | +40.65% | +248.14% | 739.71Cr | |
| -0.44% | +1.36% | -15.79% | - | 680.55Cr | |
| -1.04% | +2.69% | - | - | 561.79Cr | |
| Average | -0.67% | +1.64% | +10.06% | +49.20% | 1.02TCr | |
| Weighted average by Cap. | -0.42% | +1.15% | +11.16% | +45.29% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 1.9TCr 1.36TCr 1.16TCr 1.06TCr 1TCr 1.85TCr 1,27300Cr 12TCr 4.92TCr 61TCr 5.09TCr 4.99TCr 2,16400Cr | 1.95TCr 1.4TCr 1.19TCr 1.1TCr 1.04TCr 1.91TCr 1,31300Cr 13TCr 5.07TCr 63TCr 5.25TCr 5.14TCr 2,23100Cr |
| Net income | 30Cr 22Cr 18Cr 17Cr 16Cr 29Cr 2.03TCr 198.47Cr 78Cr 970.08Cr 81Cr 79Cr 3.44TCr | 38Cr 27Cr 23Cr 21Cr 20Cr 37Cr 2.57TCr 251.65Cr 99Cr 1.23TCr 102.69Cr 100.58Cr 4.36TCr |
| Net Debt | 721.62Cr 516.76Cr 440.95Cr 404.46Cr 382.55Cr 705.95Cr 48TCr 4.75TCr 1.87TCr 23TCr 1.94TCr 1.9TCr 82TCr | 714.96Cr 511.99Cr 436.88Cr 400.73Cr 379.02Cr 699.44Cr 48TCr 4.71TCr 1.85TCr 23TCr 1.92TCr 1.88TCr 82TCr |
| Date | Price | Change | Volume |
|---|---|---|---|
| 23/26/23 | 38.74 $ | -4.94% | 3,95,485 |
| 22/26/22 | 40.75 $ | -1.45% | 6,54,045 |
| 21/26/21 | 41.35 $ | -0.34% | 3,45,472 |
| 20/26/20 | 41.49 $ | +0.68% | 7,69,208 |
| 17/26/17 | 41.21 $ | -2.58% | 10,07,606 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Equities
- RHC Stock
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition